Cardiovascular Research · 2024 · 27 citations · 31 references
Life SciencesCell BiologyPathologyBone MetabolismCell SignalingSignal TransductionBone TissueExtracellular MatrixExtracellular Matrix BiochemistryExtracellular Matrix DepositionExtracellular Matrix RemodelingOsteogenesisArterial Wall ThickeningCalcificationCalcification PhysiologyCardiovascular Disease MortalityExtracellular Matrix CompositionMatrix Metalloproteinase Gene FamilyMatrix MetalloproteinasesVascular Calcifications
AIMS: Vascular calcification is highly prevalent in atherosclerosis, diabetes, and chronic kidney disease. It is associated with increased morbidity and mortality in patients with cardiovascular disease. Matrix metalloproteinase 3 (MMP-3), also known as stromelysin-1, is part of the large matrix metalloproteinase family. It can degrade extracellular matrix components of the arterial wall including elastin, which plays a central role in medial calcification. In this study, we sought to determine the role of MMP-3 in medial calcification. METHODS AND RESULTS: We found that MMP-3 was increased in rodent models of medial calcification as well as in vascular smooth muscle cells (SMCs) cultured in a phosphate calcification medium. It was also highly expressed in calcified tibial arteries in patients with peripheral arterial disease (PAD). Knockdown and inhibition of MMP-3 suppressed phosphate-induced SMC osteogenic transformation and calcification, whereas the addition of a recombinant MMP-3 protein facilitated SMC calcification. In an ex vivo organ culture model and a rodent model of medial calcification induced by vitamin D3, we found that MMP-3 deficiency significantly suppressed medial calcification in the aorta. We further found that medial calcification and osteogenic transformation were significantly reduced in SMC-specific MMP-3-deficient mice, suggesting that MMP-3 in SMCs is an important factor in this process. CONCLUSION: These findings suggest that MMP-3 expression in vascular SMCs is an important regulator of medial calcification and that targeting MMP-3 could provide a therapeutic strategy to reduce it and address its consequences in patients with PAD.
31
Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein
Guangbin Luo, Patricia Ducy, Marc D. McKee et al. · Nature · 1997 · 2.1K citations
Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal Disease
Jacques Blacher, Alain P. Guérin, Bruno Pannier et al. · Hypertension · 2001 · 1.4K citations
Medicine, Cardiology, Nephrology +13
Multilineage Potential of Cells From the Artery Wall
Yin Tintut, Zeni Alfonso, Trishal Saini et al. · Circulation · 2003 · 361 citations
Elastin Degradation and Calcification in an Abdominal Aorta Injury Model
Dina M. Basalyga, Dan Simionescu, Wanfen Xiong et al. · Circulation · 2004 · 316 citations · Full text